0001209191-16-149265.txt : 20161110 0001209191-16-149265.hdr.sgml : 20161110 20161110135339 ACCESSION NUMBER: 0001209191-16-149265 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161109 FILED AS OF DATE: 20161110 DATE AS OF CHANGE: 20161110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC CENTRAL INDEX KEY: 0001175505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260038620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-365-5600 MAIL ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jensen Peder CENTRAL INDEX KEY: 0001518724 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36070 FILM NUMBER: 161987241 MAIL ADDRESS: STREET 1: 420 SAW MILL RIVER ROAD CITY: ARDSLEY STATE: NY ZIP: 10502 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-11-09 0 0001175505 FIVE PRIME THERAPEUTICS INC FPRX 0001518724 Jensen Peder TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2016-11-09 4 M 0 4065 5.54 A 4065 D Common Stock 2016-11-09 4 M 0 4065 7.26 A 8130 D Common Stock 2016-11-09 4 S 0 8130 55.30 D 0 D Stock Option (right to buy) 5.54 2016-11-09 4 M 0 4065 0.00 A 2022-07-10 Common Stock 4065 0 D Stock Option (right to buy) 7.26 2016-11-09 4 M 0 4065 0.00 A 2023-07-18 Common Stock 4065 0 D The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on April 5, 2016. This option is fully vested and immediately exercisable. /s/ Francis Sarena, Attorney-in-fact 2016-11-09